Objectives: This study reports a prospectively planned analysis of patients with acute
coronary syndrome who underwent early percutaneous coronary intervention (PCI) in the …

Objective: To explore clinical and bleeding outcomes in patients enrolled in the SYNERGY
trial who had percutaneous coronary intervention (PCI) based on adherence to the dosing …

The direct thrombin inhibitor argatroban offers some significant advantages over
unfractionated heparin (UFH) and is recommended as an alternative anticoagulant during …

Anticoagulants used during percutaneous coronary intervention (PCI) should not only
prevent coronary events, but also minimize the risk of periprocedural complications. Current …

Owing to its beneficial pharmacological profile, the low-molecular-weight heparin (LMWH)
enoxaparin is increasingly being taken as an alternative to UFH in the treatment of ACS with …

Danaparoid ist als Antikoagulans bei bestehender Heparin-induzierter Thrombozytopenie
(HIT) zugelassen und stellt für Patienten mit einer HIT und mechanischem …

Aims Current guidelines give a class III recommendation to the intraprocedural use of
unfractionated heparin (UFH) in patients pretreated with enoxaparin. The aim of our study …

Objetivo El objetivo de este estudio es comparar el efecto de la enoxaparina (ENX) y la
heparina no fraccionada (HNF) intravenosas en la angioplastia primaria (AP) del infarto …

Carotid artery stenting is accepted as a less invasive alternative to carotid endarterectomy in
high-risk patients. Careful patient preparation, examination, and documentation of their …

Stroke is a major cause of morbidity and mortality worldwide, and its occurrence has major
implications for the individual, family, and healthcare system alike. Cerebral infarction …